(Q35227025)

7 August 2017

1 reference

title

Controlling cardiac arrhythmias by lengthening repolarization: rationale from experimental findings and clinical considerations (English)

1 reference

7 August 2017

Controlling Cardiac Arrhythmias by Lengthening Repolarization: Rationale from Experimental Findings and Clinical Considerationsa (English)

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

history and philosophy of science

3 December 2023

main subject

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

3 December 2023

author name string

B. N. Singh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1314032

3 December 2023

J. S. Sarma

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1314032

3 December 2023

Z. H. Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1314032

3 December 2023

C. Takanaka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1314032

3 December 2023

language of work or name

English

0 references

publication date

1 January 1992

1 reference

7 August 2017

27 January 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1314032

full work available at URL

3 December 2023

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-6632.1992.tb31011.x

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

https://nyaspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/j.1749-6632.1992.tb31011.x

3 December 2023

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Annals of the New York Academy of Sciences

3 December 2023

published in

1 reference

7 August 2017

644

1 reference

7 August 2017

187-209

1 reference

Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction

7 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB31011.X

Controlling cardiac arrhythmias: to delay conduction or to prolong refractoriness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB31011.X

Efficacy of propafenone in preventing ventricular tachycardia: inverse correlation with rate-related prolongation of conduction time

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB31011.X

Effect of antiarrhythmic drugs on mortality after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB31011.X

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB31011.X

A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB31011.X

The effect of amiodarone, a new anti-anginal drug, on cardiac muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB31011.X

Amiodarone: Historical development and pharmacologic profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB31011.X

Ventricular Refractory Periods in Relation to Rate and Test-Site VT Intervals in Anesthetized and Conscious Dogs: A Canine Model for Conscious State Measurements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB31011.X

Quinidine delays IK activation in guinea pig ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB31011.X

Effects of quinidine on plateau currents of guinea-pig ventricular myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB31011.X

Effects of quinidine on action potentials and ionic currents in isolated canine ventricular myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB31011.X

Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB31011.X

Effect of amiodarone on the expression of myosin isoforms and cellular growth of cardiac muscle cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB31011.X

Effects of thyroid hormone on the action potential and membrane currents of guinea pig ventricular myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1992.TB31011.X

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: evaluation in a conscious canine model of sudden dea

3 December 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Alterations in regional myocardial distribution and arrhythmogenic effects of aprindine produced by coronary artery occlusion in the dog

3 December 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Efficacy of procainamide on ventricular tachycardia: relation to prolongation of refractoriness and slowing of conduction

3 December 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials

3 December 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

International mexiletine and placebo antiarrhythmic coronary trial: I. Report on arrhythmia and other findings. Impact Research Group

3 December 2023

16

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Control of cardiac arrhythmias by selective lengthening of repolarization: theoretic considerations and clinical observations

3 December 2023

21

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction

3 December 2023

22

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Antifibrillatory actions of nadolol

3 December 2023

25

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Suppression of Lethal Ischemic Ventricular Arrhythmias by the Class III Agent E4031 in a Canine Model of Previous Myocardial Infarction

3 December 2023

27

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death

3 December 2023

28

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Ventricular fibrillation in a conscious canine preparation of sudden coronary death--prevention by short- and long-term amiodarone administration

3 December 2023

29

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence

3 December 2023

30

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Electrophysiologic effects of ambasilide (LU 47110), a novel class III antiarrhythmic agent, on the properties of isolated rabbit and canine cardiac muscle

3 December 2023

31

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

3 December 2023

33

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Effects of flecainide and quinidine on human atrial action potentials. Role of rate-dependence and comparison with guinea pig, rabbit, and dog tissues

3 December 2023

35

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers

3 December 2023

36

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Block of delayed rectifier potassium current, IK, by flecainide and E-4031 in cat ventricular myocytes

3 December 2023

37

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Block of heart potassium channels by clofilium and its tertiary analogs: relationship between drug structure and type of channel blocked

3 December 2023

40

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Quinidine-induced inhibition of transient outward current in cardiac muscle

3 December 2023

43

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Amiodarone and thyroid function: clinical implications during antiarrhythmic therapy

3 December 2023

53

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Thyroxine and triiodothyronine kinetics in cardiac patients taking amiodarone

3 December 2023

54

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

The effects of amiodarone on serum thyroid hormones and hepatic thyroxine 5'-monodeiodination in rats

3 December 2023

55

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Interaction of amiodarone and desethylamiodarone with solubilized nuclear thyroid hormone receptors

3 December 2023

56

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

The effect of altered thyroid state on atrial intracellular potentials

3 December 2023

57

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Acute and chronic effects of amiodarone on delayed afterdepolarization and triggered automaticity in rabbit ventricular myocardium

3 December 2023

61

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Barium-induced nondriven action potentials as a model of triggered potentials from early afterdepolarizations: significance of slow channel activity and differing effects of quinidine and amiodarone

3 December 2023

62

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Influence of thyroid hormone levels on the electrical and mechanical properties of rabbit papillary muscle

3 December 2023

64

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

Antagonism of thyroid hormone action by amiodarone in rat pituitary tumor cells

3 December 2023

65

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1992.TB31011.X

3 December 2023

Identifiers

1 reference

7 August 2017

1 reference